Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00032513
DRKS00032513
Active, not recruiting
Not Applicable

A real-world analysis of adherence barriers and reasons for non-persistence in patients receiving intravitreal therapy with anti- vascular endothelial growth factor therapy –a patient and physician survey in germany

F. Hoffmann-La Roche Ltd0 sites55 target enrollmentOctober 26, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsH35.30H35.0Background retinopathy and retinal vascular changes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
H35.30
Sponsor
F. Hoffmann-La Roche Ltd
Enrollment
55
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2023
End Date
June 2, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •The patient has been diagnosed with nAMD and/or DME
  • •The patient is at least 18 years of age (DME)/ the patient is at least 50 years of age (nAMD)
  • •The patient has started IVT with anti\-VEGF therapy in routine clinical practice \=5 years ago
  • •The patient is currently receiving (or received at the time of last injection) an anti\-VEGF agent approved in Germany for the respective indication (nAMD/DME)
  • •The patient receives all care in relation to their eye disease at one center/practice (no referral by another practice/center)
  • •To the knowledge of the treating physician, the patient has not previously received and is not currently receiving IVT with anti\-VEGF therapy at another center/practice
  • •The patient is capable of participating in a 45\-minute telephone interview in German language
  • •Basic clinical information about the patient and his/her care is available in the patient charts (minimum 6\-month medical records).

Exclusion Criteria

  • •There are no explicit exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Adherence to ART in HIV-infected Thai TravelersInfluencing factors to adherence&#45Adherence to ART in Thai HIV infected&#45travelers&#45influencing factors to ART adherence in Thai HIV infected&#45travelersHIV infected Thai travelersAdherence
TCTR20190604001Faculty of Tropical Medicine, Mahidol University440
Not yet recruiting
Not Applicable
Barriers to perform home tasks oriented soon after stroke.Sequelae of stroke, not specified as hemorrhagic or ischemicStrokeI69.4C10.228.140.300.775
RBR-9crkxrniversidade do Estado de Santa Catarina
Not yet recruiting
Not Applicable
Adherence of People Living with HIV to Tenofovir, Lamivudine, and Dolutegravir treatment and its associated factorsHealth Condition 1: B20- Human immunodeficiency virus [HIV]disease
CTRI/2024/08/072599Government Medical College, Patiala
Not yet recruiting
Not Applicable
The exploratory study of the effect on adherence improvement of the electronic edition bornchial asthma diary: Crossover randomized controlled trialBronchial Asthma
JPRN-UMIN000019657Showa University, Faculty of Medicine, Department of Pediatircs40
Completed
Not Applicable
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse BackgroundsBreast Cancer
NCT03447886Dana-Farber Cancer Institute17